A detailed history of Cribstone Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 950 shares of LLY stock, worth $748,780. This represents 0.2% of its overall portfolio holdings.

Number of Shares
950
Previous 955 0.52%
Holding current value
$748,780
Previous $309,000 12.3%
% of portfolio
0.2%
Previous 0.19%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $1,607 - $1,873
-5 Reduced 0.52%
950 $347,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1,482 - $1,689
-5 Reduced 0.52%
955 $309,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $2,787 - $3,272
10 Added 1.05%
960 $311,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $15,254 - $18,957
-65 Reduced 6.4%
950 $272,000
Q3 2020

Nov 17, 2020

SELL
$146.22 - $169.13 $14,622 - $16,913
-100 Reduced 8.97%
1,015 $150,000
Q1 2020

Apr 21, 2020

SELL
$119.05 - $147.35 $18,690 - $23,133
-157 Reduced 12.34%
1,115 $155,000
Q4 2019

Jan 08, 2020

SELL
$106.92 - $132.43 $43,730 - $54,163
-409 Reduced 24.33%
1,272 $167,000
Q3 2019

Nov 20, 2019

SELL
$106.79 - $116.16 $23,280 - $25,322
-218 Reduced 11.48%
1,681 $188,000
Q2 2019

Jul 22, 2019

SELL
$110.79 - $129.32 $324,393 - $378,648
-2,928 Reduced 60.66%
1,899 $210,000
Q1 2019

Apr 11, 2019

BUY
$111.31 - $131.02 $2,337 - $2,751
21 Added 0.44%
4,827 $626,000
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $56,127 - $62,879
-530 Reduced 9.93%
4,806 $556,000
Q3 2018

Oct 25, 2018

SELL
$85.86 - $107.31 $111,188 - $138,966
-1,295 Reduced 19.53%
5,336 $573,000
Q2 2018

Jul 24, 2018

BUY
$75.7 - $86.88 $350,112 - $401,820
4,625 Added 230.56%
6,631 $566,000
Q1 2018

Apr 19, 2018

SELL
$74.21 - $87.6 $5,343 - $6,307
-72 Reduced 3.46%
2,006 $155,000
Q4 2017

Feb 02, 2018

BUY
$81.94 - $87.89 $16,388 - $17,578
200 Added 10.65%
2,078 $176,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $144,737 - $160,644
1,878
1,878 $161,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cribstone Capital Management, LLC Portfolio

Follow Cribstone Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.